BHST BioHarvest Sciences, Inc. Total Asset Value of Company

BHST (BioHarvest) - company brandmark

BioHarvest Sciences (BHST) production facilities are located in Israel, where the implementation of innovative bioreactors ensures the stable output of eco-ingredients. This price chart illustrates the dynamics of total assets, which currently stand at 36.18. The business relies on a robotic plant mass cultivation platform that eliminates manual labor and creates high-margin custom cannabinoids, the value of which is regulated by the market for natural analogs.

BHST (BioHarvest Sciences) Company Total Assets history from 11/13/2024 to 10/30/2026
Manufactured products of BioHarvest Sciences

Total assets represent the aggregate of all resources and liabilities that form the business's material base. The dynamics of an organization's asset value demonstrate the scale of capital control available for operational expansion. This metric is calculated inversely via return on assets (ROA), which necessitates caution when analyzing quarterly spikes. For BioHarvest Sciences (BHST), growing the asset base is critically important to mitigate risks associated with logistics disruptions and the rising cost of biological raw materials.

Key competitors

HLN: Aggregate Business Assets|Aggregate Company Assets Kenvue|Verona Pharma PLC - Total Asset Value of Company|Company Total Assets MENS|LGND (Ligand Corp) - Aggregate Asset Value|Company Total Assets AMRX (Amneal Pharmaceuticals)|Company Total Assets perrigo.com PRGO|ALVO - Aggregate Company Assets|Aggregate Asset Value LQDA (Liquidia Corp)|Galapagos Genomics (GLPG) - Aggregate Company Assets|Cumulative Company Assets ANI Pharmaceuticals Corp|MNKD (MannKind Corporation) - Company Total Assets|Company Total Assets amphastar.com|Cumulative Company Assets PCRX (Pacira BioSciences, Inc.)|SPRY (ARS Pharmaceuticals Inc) - Aggregate Asset Value|Aggregate Company Assets Theravance TBPH|Aquestive Corp (AQST) - Company Assets|SCPH: Cumulative Company Assets|Tectonic Therapeutic, Inc. - Aggregate Business Assets|TNXP: Company Total Assets|China SXT Pharmaceuticals, Inc. - Aggregate Asset Value|EPRX (Eupraxia Pharmaceuticals, Inc.) - Company Total Assets|Company Assets Invizyne EXOZ|Aggregate Company Assets Oramed Pharmaceuticals (ORMP)|ENTX (enterabio.com) - Aggregate Asset Value|Company Total Assets HYFT (MindWalk Holdings Inc.)|ABVC BioPharma Inc. - Aggregate Company Assets|Cumberland Pharma - Company Total Assets|Company Total Asset Base Quantum BioPharma Corp QNTM|FibroGen, Inc. (FGEN) - Aggregate Company Assets|Company Assets telomirpharma.com (TELO)|RANI (Rani Therapeutics Holdings) - Company Total Assets|SNYR: Aggregate Asset Value|Company Total Assets RLYB|Company Total Assets lexariabioscience.com (LEXX)|Aggregate Company Assets Pulmatrix, Inc. PULM|Aggregate Asset Value PTHL|APM: Cumulative Company Assets|LYRA: Aggregate Company Assets|IBO: Company Total Assets|Company Assets TNF Pharmaceuticals, Inc. (TNFA)|Aggregate Company Assets cbdMD Inc.|painreform.com (PRFX) - Company Total Asset Base|Cumulative Company Assets CYTO (Altamira Therapeutics)|Aggregate Business Assets LIPO|Optinose - Cumulative Company Assets|Aggregate Asset Value PIRS|PROC - Aggregate Company Assets|Company Total Asset Base petrospharma.com PTPI|QLI: Company Total Assets|Cumulative Company Assets Acelyrin Inc.|TFFP (TFF Pharma) - Company Total Assets